TeleCheck-AF remote screening project goes live across Europe It’s no secret the COVID-19 pandemic is placing enormous pressure on our healthcare system. Capacity in our hospitals and clinics is stretched thin. And some patients may find it hard to get…
A world first - FibriCheck app automatically detects both silent and intermittent atrial fibrillation at night, dramatically reducing the risk of stroke in 40-plussers Hasselt, Belgium, 31 March 2020 - FibriCheck, the first CE- and FDA-approved medical app, today announces…
FibriCheck has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020 FibriCheck is thrilled to be among the new innovations joining the 2020 NIA programme. FibriCheck is an innovative, hardware-free…
Fitbit users in France, Germany, Italy and Spain can use FibriCheck to help detect heart rhythm irregularities like Atrial Fibrillation
Easy integration into any device with photoplethysmography (PPG) sensors opens up new possibilities for medical device and pharma companies . The wearables market continues to explode, and health apps are playing a big role in its expansion. People aged 55…
Fitbit users in Belgium, the Netherlands, Ireland and the United Kingdom can use FibriCheck to help detect heart rhythm irregularities like Atrial Fibrillation [Hasselt - 24 SEPTEMBER 2019] Fitbit (NYSE:FIT) and FibriCheck, an innovative health screening and monitoring app, today…
Brussels, October 8th 2018 – A new scoop for Digital Health with the FDA clearance of FibriCheck. The American watchdog, FDA, has a strict regulatory process for medical applications before they can enter the American market. FibriCheck, a Belgian medical…